James H. Mackaness, Chief Financial Officer at SOLENO THERAPEUTICS INC (SLNO), bought 6,060 shares at $1.65 ($10K) on 2020-06-26, disclosed to the SEC on 2021-09-14.
Open-market purchase of $10k SLNO by Chief Financial Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Several strong factors at once. The rarest rating we give.
| Filing → |
| SLNO | SELL | 2024-10-03 | $757K | — | Filing → |
| SLNO | SELL | 2024-08-30 | $1.1M | — | Filing → |
| SLNO | SELL | 2024-08-07 | $1.3M | — | Filing → |